Cardiovascular disease–Human/patient data: IL-17A/Th17 cells are increased in patients with acute coronary syndrome and correlate with systemic inflammation markers (36)–Animal models: IL-17A inhibition results in the reduction of the size of atherosclerotic plaques in apoE deficient mice (37). Here, IL17A is linked to acute coronary syndrome.